FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045378211> ?p ?o ?g. }

• W2045378211 endingPage "S137" @default.
• W2045378211 startingPage "S137" @default.
• W2045378211 abstract "PurposeTo evaluate changing patterns of surgical and endovascular treatment of fibroids over a ten year period and to analyze whether values beyond patient care can drive medical decisions related to the use of Uterine Fibroid Embolization (UFE).Materials and MethodsWe collected and analyzed the medical records of all patients at our institution between January 2003 and December 2013 (n=7659) with a discharge diagnosis of uterine fibroids who were treated with either surgery (open/laparoscopic myomectomy, open/ laparoscopic hysterectomy) or embolotherapy. This cohort was further sorted by payer into Medicaid, Medicare, private insurance, or self-paid/uninsured. We then reviewed literature on medical ethics and business ethics to offer an analysis of our results.ResultsThe percentages of patients treated with UFE, myomectomy, or hysterectomy remained constant over 10 years and evenly divided between the 3 procedures with essentially no growth in UFE (27% in 2003 vs 30% in 2013). Laparoscopic procedural use however increased markedly over the same period (2.55% to 24.75%). The percent of hysterectomy and myomectomy patients on Medicaid remained relatively constant but significantly increased for UFE (.03%% in 2003; 19% in 2013).ConclusionSince satisfaction rates for these procedures have been shown to be similar, one may expect uterine-preserving procedures such as laparoscopic myomectomy and UFE to experience similar growth. Despite UFE being a well-established alternative, gynecologists are consciously or unconsciously referring more patients with lower-paying insurance (Medicaid) to interventional radiology during the same time there was 400% growth in the number of laparoscopic myomectomy (1300% increase in overall laparoscopic procedures). Although incentives such as financial gains and self-referral are readily apparent they are rarely discussed in terms of specific examples and solutions. We believe a blend of business and clinical ethics may better encompass the values which motivate medical decisions and allow us to adjust medical education and systems to fit the values we hope to exemplify. PurposeTo evaluate changing patterns of surgical and endovascular treatment of fibroids over a ten year period and to analyze whether values beyond patient care can drive medical decisions related to the use of Uterine Fibroid Embolization (UFE). To evaluate changing patterns of surgical and endovascular treatment of fibroids over a ten year period and to analyze whether values beyond patient care can drive medical decisions related to the use of Uterine Fibroid Embolization (UFE). Materials and MethodsWe collected and analyzed the medical records of all patients at our institution between January 2003 and December 2013 (n=7659) with a discharge diagnosis of uterine fibroids who were treated with either surgery (open/laparoscopic myomectomy, open/ laparoscopic hysterectomy) or embolotherapy. This cohort was further sorted by payer into Medicaid, Medicare, private insurance, or self-paid/uninsured. We then reviewed literature on medical ethics and business ethics to offer an analysis of our results. We collected and analyzed the medical records of all patients at our institution between January 2003 and December 2013 (n=7659) with a discharge diagnosis of uterine fibroids who were treated with either surgery (open/laparoscopic myomectomy, open/ laparoscopic hysterectomy) or embolotherapy. This cohort was further sorted by payer into Medicaid, Medicare, private insurance, or self-paid/uninsured. We then reviewed literature on medical ethics and business ethics to offer an analysis of our results. ResultsThe percentages of patients treated with UFE, myomectomy, or hysterectomy remained constant over 10 years and evenly divided between the 3 procedures with essentially no growth in UFE (27% in 2003 vs 30% in 2013). Laparoscopic procedural use however increased markedly over the same period (2.55% to 24.75%). The percent of hysterectomy and myomectomy patients on Medicaid remained relatively constant but significantly increased for UFE (.03%% in 2003; 19% in 2013). The percentages of patients treated with UFE, myomectomy, or hysterectomy remained constant over 10 years and evenly divided between the 3 procedures with essentially no growth in UFE (27% in 2003 vs 30% in 2013). Laparoscopic procedural use however increased markedly over the same period (2.55% to 24.75%). The percent of hysterectomy and myomectomy patients on Medicaid remained relatively constant but significantly increased for UFE (.03%% in 2003; 19% in 2013). ConclusionSince satisfaction rates for these procedures have been shown to be similar, one may expect uterine-preserving procedures such as laparoscopic myomectomy and UFE to experience similar growth. Despite UFE being a well-established alternative, gynecologists are consciously or unconsciously referring more patients with lower-paying insurance (Medicaid) to interventional radiology during the same time there was 400% growth in the number of laparoscopic myomectomy (1300% increase in overall laparoscopic procedures). Although incentives such as financial gains and self-referral are readily apparent they are rarely discussed in terms of specific examples and solutions. We believe a blend of business and clinical ethics may better encompass the values which motivate medical decisions and allow us to adjust medical education and systems to fit the values we hope to exemplify. Since satisfaction rates for these procedures have been shown to be similar, one may expect uterine-preserving procedures such as laparoscopic myomectomy and UFE to experience similar growth. Despite UFE being a well-established alternative, gynecologists are consciously or unconsciously referring more patients with lower-paying insurance (Medicaid) to interventional radiology during the same time there was 400% growth in the number of laparoscopic myomectomy (1300% increase in overall laparoscopic procedures). Although incentives such as financial gains and self-referral are readily apparent they are rarely discussed in terms of specific examples and solutions. We believe a blend of business and clinical ethics may better encompass the values which motivate medical decisions and allow us to adjust medical education and systems to fit the values we hope to exemplify." @default.
• W2045378211 created "2016-06-24" @default.
• W2045378211 creator A5026141562 @default.
• W2045378211 creator A5064502755 @default.
• W2045378211 creator A5070701878 @default.
• W2045378211 date "2015-02-01" @default.
• W2045378211 modified "2023-09-24" @default.
• W2045378211 title "Fibroid treatment options: a ten year analysis of utilization and referral patterns" @default.
• W2045378211 doi "https://doi.org/10.1016/j.jvir.2014.12.368" @default.
• W2045378211 hasPublicationYear "2015" @default.
• W2045378211 type Work @default.
• W2045378211 sameAs 2045378211 @default.
• W2045378211 citedByCount "1" @default.
• W2045378211 countsByYear W20453782112021 @default.
• W2045378211 crossrefType "journal-article" @default.
• W2045378211 hasAuthorship W2045378211A5026141562 @default.
• W2045378211 hasAuthorship W2045378211A5064502755 @default.
• W2045378211 hasAuthorship W2045378211A5070701878 @default.
• W2045378211 hasConcept C126322002 @default.
• W2045378211 hasConcept C141071460 @default.
• W2045378211 hasConcept C160735492 @default.
• W2045378211 hasConcept C162324750 @default.
• W2045378211 hasConcept C2776135927 @default.
• W2045378211 hasConcept C2776534028 @default.
• W2045378211 hasConcept C2779494336 @default.
• W2045378211 hasConcept C2779607476 @default.
• W2045378211 hasConcept C2780566971 @default.
• W2045378211 hasConcept C50522688 @default.
• W2045378211 hasConcept C512399662 @default.
• W2045378211 hasConcept C61434518 @default.
• W2045378211 hasConcept C71924100 @default.
• W2045378211 hasConcept C72563966 @default.
• W2045378211 hasConceptScore W2045378211C126322002 @default.
• W2045378211 hasConceptScore W2045378211C141071460 @default.
• W2045378211 hasConceptScore W2045378211C160735492 @default.
• W2045378211 hasConceptScore W2045378211C162324750 @default.
• W2045378211 hasConceptScore W2045378211C2776135927 @default.
• W2045378211 hasConceptScore W2045378211C2776534028 @default.
• W2045378211 hasConceptScore W2045378211C2779494336 @default.
• W2045378211 hasConceptScore W2045378211C2779607476 @default.
• W2045378211 hasConceptScore W2045378211C2780566971 @default.
• W2045378211 hasConceptScore W2045378211C50522688 @default.
• W2045378211 hasConceptScore W2045378211C512399662 @default.
• W2045378211 hasConceptScore W2045378211C61434518 @default.
• W2045378211 hasConceptScore W2045378211C71924100 @default.
• W2045378211 hasConceptScore W2045378211C72563966 @default.
• W2045378211 hasIssue "2" @default.
• W2045378211 hasLocation W20453782111 @default.
• W2045378211 hasOpenAccess W2045378211 @default.
• W2045378211 hasPrimaryLocation W20453782111 @default.
• W2045378211 hasRelatedWork W2034774605 @default.
• W2045378211 hasRelatedWork W2064889388 @default.
• W2045378211 hasRelatedWork W2068195493 @default.
• W2045378211 hasRelatedWork W2205036001 @default.
• W2045378211 hasRelatedWork W2394144378 @default.
• W2045378211 hasRelatedWork W2414068187 @default.
• W2045378211 hasRelatedWork W2912049116 @default.
• W2045378211 hasRelatedWork W3048914904 @default.
• W2045378211 hasRelatedWork W4206904404 @default.
• W2045378211 hasRelatedWork W4253890724 @default.
• W2045378211 hasVolume "26" @default.
• W2045378211 isParatext "false" @default.
• W2045378211 isRetracted "false" @default.
• W2045378211 magId "2045378211" @default.
• W2045378211 workType "article" @default.